Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_assertion type Assertion NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_head.
- NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_assertion description "[Targeted testing for these three mutations (BRCA1 187delAG, BRCA1 5385insC, and BRCA2 6174delT) is therefore recommended for all AJ breast and ovarian cancer patients, regardless of age of diagnosis or family history.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_provenance.
- NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_assertion evidence source_evidence_literature NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_provenance.
- NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_assertion SIO_000772 25476495 NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_provenance.
- NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_assertion wasDerivedFrom befree-2016 NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_provenance.
- NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_assertion wasGeneratedBy ECO_0000203 NP1244940.RAaiKPY-dblk8bJK-SaCzom-u8Shty0IvUIQtxI2PQYUU130_provenance.